Order results by:
| Issue | Title | |
| Vol 8, No 2 (2012) | EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva | ||
| "... Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases ..." | ||
| Vol 8, No 4 (2012) | ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? | Abstract similar documents |
| I. V. Zhirov | ||
| "... The results of recent trials on acetylsalicylic acid (ASA) efficacy are presented. Data ..." | ||
| Vol 17, No 4 (2021) | Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology | Abstract similar documents |
| M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov | ||
| "... manifestations of CVD. All patients received acetylsalicylic acid (ASA) 75 mg daily. Along with a comprehensive ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... by therapies. There were not significant inter-group differences. Conclusion. ASA generic medicine Acecardol ..." | ||
| Vol 7, No 4 (2011) | ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID | Abstract similar documents |
| I. N. Bokarev, L. V. Popova | ||
| "... An experience of acetylsalicylic acid (ASA) clinical use since its synthesis in 1887 ..." | ||
| Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
| "... characteristics of blood and platelets were found in the groups of ASA-resistant and ASA-sensitive patients 10 ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... Use of acetylsalicylic acid (ASA) in cardiology practice is presented. ASA modes of action ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... 140 patients in the acetylsalicylic acid (ASA) treatment group and 103 patients in the dual ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... of serum thromboxane B2 were studied in the compared groups. Results. The average release profile of ASA ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and clopidogrel and clinical ..." | ||
| Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
| "... guidelines for the treatment of AH determine specific approaches for managing patients of older age groups ..." | ||
| Vol 9, No 4 (2013) | ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES | Abstract similar documents |
| E. N. Dankovtseva | ||
| "... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... as a drug of choice from the P2Y12 inhibitor group, the use of low doses of acetylsalicylic acid (ASA ..." | ||
| Vol 5, No 4 (2009) | GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY | Abstract similar documents |
| A. L. Komarov | ||
| "... Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic acid (ASA) use ..." | ||
| Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
| I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
| "... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..." | ||
| Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
| "... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..." | ||
| Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract similar documents |
| D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
| "... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and clopidogrel resistance ..." | ||
| Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
| A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
| "... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..." | ||
| Vol 5, No 6 (2009) | RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky | ||
| "... to acetylsalicylic acid (ASA) therapy. Material and methods. 200 patients with ACS (aged 56,6±9,2 y.o.) were ..." | ||
| Vol 15, No 4 (2019) | Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital | Abstract similar documents |
| O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova | ||
| "... Aim. To study detection of atrial septal aneurysm (ASA) by transthoracic echocardiography ..." | ||
| Vol 5, No 5 (2009) | EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi | ||
| "... in 3 groups depending on prescribed antiplatelets (acetylsalicylic acid; clopidogrel; acetylsalicylic ..." | ||
| Vol 17, No 1 (2021) | Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease | Abstract similar documents |
| M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush | ||
| "... bypass grafting (CABG), depending on sensitivity to acetylsalicylic acid (ASA). Material and methods ..." | ||
| Vol 15, No 3 (2019) | Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery | Abstract similar documents |
| A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein | ||
| "... with acetylsalicylic acid (ASA) resistance in patients with coronary heart disease after coronary bypass surgery (CABG ..." | ||
| Vol 20, No 6 (2024) | Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski | ||
| "... of myocardial infarction (MI) during the administration of acetylsalicylic acid (ASA) as part of dual ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| "... статинов в качестве препаратов, позволяющих снизить риск сердечно-сосудистых осложнений. Приведены ..." | ||
| Vol 14, No 1 (2018) | STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) | Abstract similar documents |
| S. V. Povetkin, Ju. V. Luneva | ||
| "... into the Group 1 receiving the original (Coraxan®, Servier,Serdix,Russia) or Group 2 receiving generic (Raenom ..." | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... Цель. Сравнить эффективность и переносимость двух препаратов — вазодилататора (изосорбида-5 ..." | ||
| Vol 3, No 4 (2007) | RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi | ||
| "... sensitivity to acetylsalicylic acids (ASA) in patients with stable angina. Material and methods. 96 patients ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... groups with a history of myocardial infarction by the example of outpatient cardiology institution ..." | ||
| Vol 2, No 4 (2006) | QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? | Abstract similar documents |
| V. V. Iakusevich | ||
| "... with original drug in parallel groups. The examples of the generics with such evidences are demonstrated ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... that risk associated with acetylsalicylic acid (ASA) use in patients ≥75 years can overweigh its potential ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| "... (АСК) в кардиологической практике. Особое внимание уделяется дженерическим препаратам АСК, применение ..." | ||
| Vol 21, No 1 (2025) | Assessment of self-treatment in terms of inappropriate prescribing registry | Abstract similar documents |
| S. Yu. Martsevich, V. V. Tsaregorodtseva, N. P. Kutishenko, Yu. V. Lukina, A. V. Zagrebelnyi, I. V. Mihailova, O. M. Drapkina | ||
| "... in the groups with and without self-medication, except for the presence of a history of acute cerebrovascular ..." | ||
| Vol 7, No 5 (2011) | THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman | ||
| "... . Complex therapy (acetylsalicylic acid (ASA), beta-blockers (BB), ACE inhibitors, statins) was prescribed ..." | ||
| Vol 8, No 2 (2012) | THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev | ||
| "... .5%), were included in the multi-center open randomized study with parallel groups. Patients were randomized ..." | ||
| Vol 1, No 1 (2005) | DRUGS AND SMOKING | Abstract similar documents |
| J. V. Lukina | ||
| "... in patients of both groups was evaluated by burden tests on treadmill, effective doses of bisoprolol ..." | ||
| Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
| "... randomized to receive generic (Group 1) or original (Group 2) amlodipine in the initial dose of 5 mg daily ..." | ||
| Vol 5, No 6 (2009) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina | ||
| "... were split into 2 groups. Study duration was 10 weeks. Efficacy control, dose correction, addition ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... echocardiography, before and af- ter treatment. Control group contained 16 healthy individuals Results. Disorders ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... ) were achieved in 10 (71.4%) patients in each group. After 8 weeks of therapy with generic and original ..." | ||
| Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... into group A or group B. Patients of group A (n=18) received original simvastatin, patients of group B (n=20 ..." | ||
| Vol 6, No 6 (2010) | WORKING GROUP OF THE YOUNG CARDIOLOGISTS HAS BEEN ESTABLISHED AT THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION | Abstract similar documents |
| "... Working group of the Young Cardiologists has been established at the Society of Cardiology ..." | ||
| Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
| E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
| "... /effectiveness ratio were evaluated. Results. In group A (fixed combination of original enalapril ..." | ||
| Vol 3, No 2 (2007) | ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY | Abstract similar documents |
| N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, S. Y. Martsevich | ||
| "... no differences between basic clinical characteristics in groups of patients initially treated with different ..." | ||
| Vol 9, No 5 (2013) | THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL | Abstract similar documents |
| A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva | ||
| "... ) was found in patients of Parnavel group by 28 mm Hg (19%) and 17 mm Hg (19%), respectively. In the patients ..." | ||
| Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
| "... examined. Patients were randomized into group 1 (original bisoprolol 5 mg/day) or group 2 (generic ..." | ||
| Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
| R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
| "... with ischemic heart disease (IHD) in different age groups. Material and methods. Patients (n=678) with IHD aged ..." | ||
| Vol 10, No 1 (2014) | ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW | Abstract similar documents |
| O. N. Semenova, E. A. Naumova, Yu. G. Schwartz | ||
| "... with adherence to treatment for chronic cardiovascular diseases in the group focused interview of patients ..." | ||
| Vol 18, No 1 (2022) | The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" | Abstract similar documents |
| M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok | ||
| "... Aim. To assess the outcomes of combination therapy with rivaroxaban and acetylsalicylic acid (ASA ..." | ||
| Vol 3, No 3 (2007) | COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich | ||
| "... .5%/71.9% of patients in Concor group and in 43.7%/62.5% of patients in Bisogamma group ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... ) is comparable to that in the placebo group. Some antihypertensive drugs are used to prevent migraine attacks. ..." | ||
| Vol 16, No 5 (2020) | Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation | Abstract similar documents |
| E. P. Popova, S. S. Puzin, O. T. Bogova, S. N. Puzin, D. A. Sychev, V. P. Fisenko | ||
| "... ), low frequencies (LF) and high frequencies (HF). Results. In the group of patients with newly ..." | ||
| Vol 13, No 3 (2017) | COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebelnyy, M. M. Loukianov, A. N. Vorobyev, E. A. Pravkina, N. O. Myasnikova | ||
| "... On Behalf of the Working Groups of the Registries PROFILE and REСVASA. Working Group ..." | ||
| Vol 5, No 5 (2009) | INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| N. V. Egorkina, V. M. Gorbunov, E. S. Abirova | ||
| "... Представлены результаты исследований влияния различных групп антигипертензивных препаратов на ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... . Patients were randomized in 2 groups (G1 and G2): G1 patients (n=15) received Zocor 20 mg/day during 6 ..." | ||
| Vol 13, No 5 (2017) | CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM | Abstract similar documents |
| V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova | ||
| "... of cardiovascular complications risk in the chronotherapy group. However, the study had serious limitations ..." | ||
| Vol 15, No 5 (2019) | Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them | Abstract similar documents |
| N. V. Pyrikova, O. N. Antropova, I. V. Osipova | ||
| "... , the prescription of this group of drugs requires consideration of the potential risks of complications, including ..." | ||
| Vol 9, No 1 (2013) | POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova | ||
| "... and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA ..." | ||
| Vol 12, No 4 (2016) | High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova | ||
| "... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..." | ||
| Vol 20, No 2 (2024) | Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry | Abstract similar documents |
| V. S. Arakelyan, A. D. Erlikh, N. Sh. Amirov, E. Dubar, K. Vogtlaender, S. Debus | ||
| "... inhibition therapy with rivaroxaban 2,5 mg twice a day and low-dose acetylsalicylic acid (ASA) daily were ..." | ||
| Vol 12, No 1 (2016) | Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease | Abstract similar documents |
| E. I. Tarlovskaya, T. I. Chudinovskikh | ||
| "... into the study. Patients were randomized into group A (received therapy based on the original bisoprolol ..." | ||
| Vol 8, No 4 (2012) | THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova | ||
| "... to receive trimetazidine 35 mg 2 times a day (intervention group) or placebo (control group) in addition ..." | ||
| Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
| M. S. Soboleva, Е. E. Loskutova | ||
| "... .8%) and bisoprolol (from 2.4% to 20.3%); in group of angiotensin converting enzyme inhibitors – enalapril (from 3 ..." | ||
| Vol 10, No 5 (2014) | USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES | Abstract similar documents |
| V. R. Abdrakhmanov, N. I. Gaponova, N. F. Plavunov | ||
| "... and peripheral mode of actions are reviewed. Target groups of patients for urapidil use are specified. Dosage ..." | ||
| Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
| "... . Patients were randomized for treatment with the original bisoprolol (1st group; n=36) and the generic ..." | ||
| Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
| E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
| "... . Results. 75 % of Vedikardol-group patients and 75 % of Dilatrend-group patients had reached target BP ..." | ||
| Vol 19, No 2 (2023) | Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease | Abstract similar documents |
| D. A. Tsaregorodtsev, M. A. Khalikova, S. S. Vasyukov, M. M. Beraya, A. V. Sedov | ||
| "... paroxysms. Patients was divided into the lappaconitine hydrobromide group (LH group; n=26), the propafenone ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... . In the prescription structure of pharmacological groups changes were detected concerning the preferred choice ..." | ||
| Vol 4, No 3 (2008) | INFLUENCE OF COMBINED ANTIHYPERTENSIVE AND ANTIDEPRESSANT THERAPY ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION, ANXIETY AND DEPRESSION | Abstract similar documents |
| Y. A. Vasyuk, T. V. Dovzenko, E. A. Nesterova, I. A. Sadulaeva, K. V. Tarasova | ||
| "... involved in the study. 64 patients (60,4%) had concomitant AD. All patients were divided into 3 groups. 46 ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... groups. The patients were randomized into two groups: the group 1 (n=53) started treatment ..." | ||
| Vol 9, No 5 (2013) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva | ||
| "... .6±11.1/10.4±11.3 mm Hg in LODOZ® group and -22.9±9.7/11.7±13.5 mm Hg in BISANGIL® group (p<0 ..." | ||
| Vol 15, No 5 (2019) | Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017 | Abstract similar documents |
| O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov | ||
| "... of 12 groups of internal diseases purchased in 2017 by the «key» medical organizations in the subjects ..." | ||
| Vol 3, No 5 (2007) | EFFECT OF ANTIHYPERTENSIVE THERAPY BASED ON NEW METHOD OF INDIVIDUAL CHOICE OF DRUGS ON LEFT VENTRICULAR HYPERTROPHY IN ELDERLY PATIENTS | Abstract similar documents |
| K. I. Pshenichkin | ||
| "... in two groups (30 people in each one). Patients of the group-I had common antihypertensive therapy ..." | ||
| Vol 8, No 1 (2012) | THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov | ||
| "... was evaluated in 12-month comparative randomized study. Patients of the first group (n=97) received standard ..." | ||
| Vol 12, No 1 (2016) | A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register | Abstract similar documents |
| A. V. Zakharova, S. N. Tolpygina, V. P. Voronina, S. Yu. Martsevich | ||
| "... .3% women) were included into the open comparative randomized controlled study in parallel groups. After ..." | ||
| Vol 15, No 1 (2019) | Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination | Abstract similar documents |
| O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec | ||
| "... with stage II grade 1-2 essential arterial hypertension. Methods. A group of patients with stage II grade 1 ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... , adherent and non-adherent to statins, revealed the economic advantage of statins in groups of adherent ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... . Patients were divided into two groups according to taking/not-taking NOAC. Analysis of the facts ..." | ||
| Vol 4, No 4 (2008) | EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY | Abstract similar documents |
| V. V. Jakusevich, N. V. Semenova, I. A. Tihomirova, A. V. Muravyov, S. V. Lychenko | ||
| "... randomized (3:1) on Memoplant (240 mg/daily) treatment group and control group. Duration of observation ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov | ||
| "... randomized into two groups. Patients of the group 1 (n=105) received standard treatment for ischemic stroke ..." | ||
| Vol 8, No 1 (2012) | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova | ||
| "... Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland ..." | ||
| Vol 11, No 4 (2015) | EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION | Abstract similar documents |
| I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov | ||
| "... + biologics group than in MTX only group [DDLV incidence remained unchanged - 7 (28%), and DDRV incidence ..." | ||
| Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
| P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
| "... a new generation of SPC components belonging to different pharmacological groups. The combination ..." | ||
| Vol 16, No 4 (2020) | The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... and microvascular complications of diabetes. Patients with AH and diabetes belong to group with high and very high ..." | ||
| Vol 17, No 1 (2021) | Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review) | Abstract similar documents |
| O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko | ||
| "... of polymorbidity occurring in all age groups in both sexes is cardiometabolic, which is based on the formation ..." | ||
| Vol 20, No 1 (2024) | Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study | Abstract similar documents |
| Yu. A. Balanova, S. A. Shalnova, V. A. Kutsenko, A. E. Imaeva, O. E. Ivlev, S. E. Evstifeeva, A. V. Kapustina, M. B. Kotova, S. A. Maksimov, G. A. Muromtseva, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, O. A. Bashkina, S. V. Glukhovskaya, I. A. Levina, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovieva, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, E, V. Mikhailov, Yu. O. Tarabrina, M. G. Ataev, M. O. Radzhabov, Z. M. Gasanova, M. A. Umetov, I. A. Hakuasheva, i. V. Elgarova, E. I. Yamashkina, L. А. Balykova, A. A. Usanova, A. M. Nikitina, N. V. Savvina, Iu. E. Spiridonova, E. A. Naumova, V. S. Yudin, A. A. Keskinov, S. M. Yudin, A. V. Kontsevaya, O. M. Drapkina | ||
| "... .1 environment. Comparison of discrete indicators between groups was performed using Fisher’s exact test ..." | ||
| Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
| "... recommended ACEI/ARA (88.1%) and BB (98.8%) at discharge from hospital. Not prescribing of these groups ..." | ||
| Vol 11, No 4 (2015) | CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, I. Z. Loriya | ||
| "... groups: group 1 included patients with arterial hypertension (n=61), group 2 - patients with ischemic ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... to group A (n=53) received clopidogrel 75 mg daily for 7 days before PCI, and later were allocated ..." | ||
| Vol 15, No 3 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State | Abstract similar documents |
| I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova | ||
| "... atherosclerosis and osteoporosis. Currently, various groups of drugs for the treatment of osteoporosis have been ..." | ||
| Vol 3, No 1 (2007) | EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova | ||
| "... randomized in two parallel groups of patients receiving Eltacine or placebo additionally to standard therapy ..." | ||
| Vol 15, No 2 (2019) | Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction | Abstract similar documents |
| A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh | ||
| "... STEMI-patients undergoing pharmacoinvasive reperfusion (reference event) were divided into 4 groups ..." | ||
| Vol 5, No 2 (2009) | INNOVATIVE ANTIHYPERTENSIVE THERAPY IN THE LIGHT OF COMPLETED CLINICAL TRIALS | Abstract similar documents |
| N. A. Nikolaev | ||
| "... применения препаратов различных групп, в том числе в виде комбинаций. ..." | ||
| Vol 14, No 5 (2018) | The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness | Abstract similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| "... to the medical records data, a group of untreated patients with stage II grade 1-2 HT (n=100, 47 men, mean age ..." | ||
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... people: 16 healthy volunteers (control group) and 28 patients with essential HT aged 40 to 71 years ..." | ||
| Vol 14, No 3 (2018) | COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU | Abstract similar documents |
| S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca | ||
| "... of doctor’s prescriptions in Kursk and Chisinau, considered both for group of antihypertensive drugs ..." | ||
| Vol 16, No 6 (2020) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy | Abstract similar documents |
| N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva, S. Yu. Martsevich | ||
| "... are enrolled in the study group of the TRUST study who participated in one or more randomized clinical trials ..." | ||
| Vol 3, No 3 (2007) | COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS | Abstract similar documents |
| E. G. Nurtdinova, A. N. Zakirova, T. B. Khairetdinova | ||
| "... were split into three groups. Group I (25 persons) received monotherapy with magnesium orotate ..." | ||
| 1 - 100 of 1286 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
